GlassScriptPhysician profile
Robert D Simon
NPI 1699857466
$156,108.53
in general payments reported to CMS, 2019-2025
16 companies · $1,585 in 2025
The $1,585 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $28K · 2021: $44K · 2022: $38K · 2023: $22K · 2024: $6,100 · 2025: $1,585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $30K · Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $29,549.57 |
| Food and Beverage | $209.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nutech Spine, INC. | $153,583.16 | 2019-2025 | Sifix |
| Spineology INC. | $1,262.80 | 2019-2021 | |
| Alevio, LLC | $315.94 | 2020 | |
| Stryker Corporation | $261.23 | 2019-2021 | |
| Corelink, LLC | $131.14 | 2019 | |
| Zavation Medical Products, LLC | $110.17 | 2021 | |
| Ermi LLC | $103.79 | 2024-2025 | |
| Medtronic, INC. | $73.23 | 2021 | |
| Southern Edge Orthopaedics, INC. | $69.48 | 2024-2025 | |
| Embody, INC. | $54.29 | 2021 | |
| Boston Scientific Corporation | $38.55 | 2021-2023 | |
| Pacira Pharmaceuticals Incorporated | $28.20 | 2020-2021 | |
| Baxter Healthcare | $23.01 | 2019 | |
| Pfizer INC. | $21.23 | 2024 | |
| Orthofix Medical, INC. | $19.59 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.